Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Discovery | 19 | 2023 | 1057 | 3.090 |
Why?
|
Molecular Probes | 10 | 2023 | 316 | 2.950 |
Why?
|
Endoribonucleases | 8 | 2023 | 228 | 2.740 |
Why?
|
Drug Design | 16 | 2017 | 1078 | 2.100 |
Why?
|
Muscarinic Antagonists | 5 | 2015 | 137 | 1.920 |
Why?
|
Sulfinic Acids | 6 | 2019 | 13 | 1.730 |
Why?
|
Small Molecule Libraries | 7 | 2019 | 721 | 1.500 |
Why?
|
Proteins | 9 | 2023 | 6096 | 1.450 |
Why?
|
Fluorides | 2 | 2023 | 126 | 1.440 |
Why?
|
Reverse Transcriptase Inhibitors | 6 | 2011 | 615 | 1.350 |
Why?
|
Quinazolines | 5 | 2017 | 1355 | 1.250 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 3 | 2015 | 104 | 1.240 |
Why?
|
Click Chemistry | 5 | 2019 | 95 | 1.210 |
Why?
|
Ubiquitin-Protein Ligases | 4 | 2023 | 1860 | 1.070 |
Why?
|
Enzyme Inhibitors | 7 | 2019 | 3800 | 1.060 |
Why?
|
Bronchodilator Agents | 3 | 2015 | 502 | 1.040 |
Why?
|
Proteome | 5 | 2023 | 1790 | 1.040 |
Why?
|
Molecular Targeted Therapy | 6 | 2020 | 2723 | 1.010 |
Why?
|
Protein Kinase Inhibitors | 9 | 2023 | 5522 | 1.010 |
Why?
|
MAP Kinase Kinase Kinases | 2 | 2015 | 261 | 0.870 |
Why?
|
Patents as Topic | 2 | 2015 | 103 | 0.850 |
Why?
|
Tyrosine | 3 | 2016 | 1460 | 0.820 |
Why?
|
Cysteine | 5 | 2023 | 873 | 0.810 |
Why?
|
Drug Evaluation, Preclinical | 4 | 2019 | 1372 | 0.800 |
Why?
|
Structure-Activity Relationship | 15 | 2020 | 3133 | 0.790 |
Why?
|
Chemistry, Pharmaceutical | 5 | 2017 | 282 | 0.750 |
Why?
|
Imidazoles | 5 | 2011 | 1205 | 0.750 |
Why?
|
Proteomics | 6 | 2019 | 3618 | 0.740 |
Why?
|
Janus Kinase 3 | 2 | 2017 | 78 | 0.730 |
Why?
|
Molecular Structure | 15 | 2019 | 1907 | 0.720 |
Why?
|
Photoaffinity Labels | 2 | 2021 | 86 | 0.720 |
Why?
|
Down-Regulation | 2 | 2017 | 3001 | 0.710 |
Why?
|
Polymers | 2 | 2022 | 1618 | 0.700 |
Why?
|
Cell Membrane Permeability | 4 | 2016 | 590 | 0.680 |
Why?
|
CREB-Binding Protein | 2 | 2017 | 151 | 0.670 |
Why?
|
Sulfuric Acids | 1 | 2017 | 37 | 0.620 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2015 | 3038 | 0.610 |
Why?
|
Biological Assay | 1 | 2020 | 652 | 0.600 |
Why?
|
HIV Reverse Transcriptase | 4 | 2011 | 213 | 0.600 |
Why?
|
Protein Processing, Post-Translational | 3 | 2020 | 1989 | 0.590 |
Why?
|
RNA Cap-Binding Proteins | 1 | 2016 | 16 | 0.580 |
Why?
|
Muscular Atrophy, Spinal | 2 | 2017 | 258 | 0.580 |
Why?
|
Phosphotransferases | 1 | 2017 | 309 | 0.570 |
Why?
|
Urea | 2 | 2008 | 449 | 0.550 |
Why?
|
Microsomes, Liver | 4 | 2017 | 175 | 0.550 |
Why?
|
Receptor, Muscarinic M3 | 2 | 2015 | 33 | 0.540 |
Why?
|
Protein Kinases | 3 | 2018 | 1638 | 0.540 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 670 | 0.530 |
Why?
|
Lysosomes | 1 | 2020 | 893 | 0.500 |
Why?
|
Fluorescent Dyes | 2 | 2016 | 1915 | 0.490 |
Why?
|
Models, Molecular | 13 | 2019 | 5454 | 0.490 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1333 | 0.480 |
Why?
|
Lysine | 2 | 2018 | 1008 | 0.480 |
Why?
|
Vaccines, Synthetic | 2 | 2015 | 633 | 0.480 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2016 | 419 | 0.470 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 527 | 0.470 |
Why?
|
Pyrroles | 2 | 2017 | 1143 | 0.460 |
Why?
|
Serine | 1 | 2017 | 828 | 0.460 |
Why?
|
Molecular Conformation | 5 | 2018 | 563 | 0.450 |
Why?
|
Temperature | 3 | 2016 | 2207 | 0.450 |
Why?
|
Pyrimidines | 4 | 2019 | 2933 | 0.450 |
Why?
|
Sulfur Compounds | 3 | 2009 | 31 | 0.450 |
Why?
|
Drug Industry | 2 | 2016 | 744 | 0.440 |
Why?
|
Reactive Nitrogen Species | 1 | 2012 | 35 | 0.440 |
Why?
|
Crystallography, X-Ray | 6 | 2017 | 2014 | 0.440 |
Why?
|
Receptors, Glucagon | 1 | 2013 | 92 | 0.430 |
Why?
|
Oligonucleotides | 2 | 2012 | 572 | 0.420 |
Why?
|
Administration, Inhalation | 3 | 2011 | 1104 | 0.420 |
Why?
|
Biology | 1 | 2014 | 292 | 0.420 |
Why?
|
Biomarkers, Pharmacological | 1 | 2013 | 162 | 0.420 |
Why?
|
Amino Acids | 2 | 2021 | 1727 | 0.390 |
Why?
|
Thermodynamics | 2 | 2009 | 594 | 0.390 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2013 | 334 | 0.370 |
Why?
|
Stereoisomerism | 6 | 2016 | 625 | 0.370 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2011 | 189 | 0.370 |
Why?
|
Carbonic Anhydrase II | 1 | 2009 | 23 | 0.360 |
Why?
|
Adrenergic beta-Agonists | 1 | 2011 | 346 | 0.360 |
Why?
|
Pharmaceutical Preparations | 2 | 2016 | 1071 | 0.360 |
Why?
|
Triazoles | 1 | 2015 | 907 | 0.350 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2009 | 95 | 0.340 |
Why?
|
Rare Diseases | 1 | 2014 | 554 | 0.340 |
Why?
|
Pyrazoles | 4 | 2017 | 1970 | 0.330 |
Why?
|
Survival of Motor Neuron 2 Protein | 3 | 2017 | 48 | 0.330 |
Why?
|
Molecular Imaging | 1 | 2015 | 831 | 0.320 |
Why?
|
Phenylenediamines | 1 | 2008 | 90 | 0.320 |
Why?
|
Amides | 1 | 2011 | 458 | 0.320 |
Why?
|
RNA, Messenger | 4 | 2017 | 13029 | 0.310 |
Why?
|
Fluorine | 1 | 2007 | 83 | 0.310 |
Why?
|
Ethers | 1 | 2007 | 75 | 0.300 |
Why?
|
Eukaryotic Cells | 2 | 2020 | 198 | 0.300 |
Why?
|
Indazoles | 1 | 2009 | 287 | 0.300 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2007 | 248 | 0.290 |
Why?
|
Humans | 62 | 2023 | 742088 | 0.290 |
Why?
|
Nitriles | 1 | 2011 | 952 | 0.270 |
Why?
|
Mass Spectrometry | 5 | 2019 | 2203 | 0.260 |
Why?
|
Binding Sites | 8 | 2021 | 6115 | 0.260 |
Why?
|
Drug Delivery Systems | 2 | 2017 | 2217 | 0.250 |
Why?
|
Leukocytes, Mononuclear | 3 | 2017 | 1835 | 0.250 |
Why?
|
Cells, Cultured | 9 | 2019 | 19223 | 0.250 |
Why?
|
Validation Studies as Topic | 2 | 2016 | 159 | 0.250 |
Why?
|
Antiviral Agents | 3 | 2016 | 2978 | 0.240 |
Why?
|
Anti-Inflammatory Agents | 1 | 2013 | 1788 | 0.230 |
Why?
|
Anti-HIV Agents | 3 | 2009 | 4250 | 0.230 |
Why?
|
Catalytic Domain | 2 | 2017 | 699 | 0.230 |
Why?
|
Cell Line | 5 | 2022 | 15994 | 0.230 |
Why?
|
Bronchoconstriction | 2 | 2015 | 141 | 0.220 |
Why?
|
Sulfur | 1 | 2023 | 166 | 0.220 |
Why?
|
Lipids | 3 | 2012 | 3302 | 0.220 |
Why?
|
Glycoconjugates | 1 | 2002 | 87 | 0.210 |
Why?
|
Animals | 24 | 2020 | 168561 | 0.210 |
Why?
|
Sulfhydryl Compounds | 2 | 2015 | 296 | 0.210 |
Why?
|
Chromatography, Affinity | 1 | 2023 | 549 | 0.210 |
Why?
|
Glycolipids | 1 | 2002 | 205 | 0.210 |
Why?
|
Adenosine Triphosphate | 3 | 2017 | 2024 | 0.200 |
Why?
|
Diazonium Compounds | 1 | 2021 | 18 | 0.200 |
Why?
|
Polymerization | 1 | 2022 | 163 | 0.200 |
Why?
|
Hemoglobin A | 1 | 2020 | 87 | 0.190 |
Why?
|
Periodicals as Topic | 1 | 2012 | 1431 | 0.190 |
Why?
|
Protein Binding | 6 | 2017 | 9387 | 0.190 |
Why?
|
Hemoglobin, Sickle | 1 | 2020 | 122 | 0.180 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 2866 | 0.180 |
Why?
|
Serum Albumin, Bovine | 2 | 2011 | 324 | 0.180 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13655 | 0.180 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2008 | 2231 | 0.180 |
Why?
|
Ubiquitination | 2 | 2022 | 1011 | 0.180 |
Why?
|
Guinea Pigs | 2 | 2011 | 1386 | 0.170 |
Why?
|
HEK293 Cells | 3 | 2017 | 4200 | 0.170 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13019 | 0.160 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2019 | 10943 | 0.160 |
Why?
|
Diphosphonates | 1 | 2002 | 625 | 0.150 |
Why?
|
Isothiocyanates | 1 | 2017 | 51 | 0.150 |
Why?
|
Enzyme Stability | 1 | 2017 | 210 | 0.150 |
Why?
|
Myotonic Dystrophy | 1 | 2017 | 78 | 0.150 |
Why?
|
Benzbromarone | 1 | 2016 | 5 | 0.140 |
Why?
|
E1A-Associated p300 Protein | 1 | 2017 | 131 | 0.140 |
Why?
|
Janus Kinases | 1 | 2017 | 244 | 0.140 |
Why?
|
Models, Chemical | 2 | 2008 | 626 | 0.140 |
Why?
|
Prokaryotic Cells | 1 | 2016 | 48 | 0.140 |
Why?
|
Chromans | 1 | 2016 | 122 | 0.140 |
Why?
|
Ipratropium | 1 | 2015 | 18 | 0.140 |
Why?
|
Tritium | 1 | 2016 | 746 | 0.140 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2016 | 115 | 0.140 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2016 | 106 | 0.140 |
Why?
|
Inhibitory Concentration 50 | 3 | 2017 | 459 | 0.140 |
Why?
|
Shock, Septic | 1 | 2002 | 773 | 0.130 |
Why?
|
Quinolines | 1 | 2020 | 719 | 0.130 |
Why?
|
RGS Proteins | 1 | 2015 | 77 | 0.130 |
Why?
|
Nucleotidyltransferases | 1 | 2017 | 220 | 0.130 |
Why?
|
Molecular Dynamics Simulation | 2 | 2016 | 413 | 0.130 |
Why?
|
Dogs | 3 | 2017 | 3910 | 0.130 |
Why?
|
Binding, Competitive | 1 | 2017 | 1159 | 0.130 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 253 | 0.130 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1659 | 0.130 |
Why?
|
Macrolides | 1 | 2016 | 201 | 0.130 |
Why?
|
Heterocyclic Compounds | 1 | 2016 | 249 | 0.130 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2023 | 1581 | 0.130 |
Why?
|
Biological Availability | 1 | 2015 | 396 | 0.130 |
Why?
|
Ligands | 2 | 2022 | 3293 | 0.120 |
Why?
|
Cattle | 2 | 2011 | 3923 | 0.120 |
Why?
|
Catalysis | 1 | 2016 | 760 | 0.120 |
Why?
|
Drug Repositioning | 1 | 2017 | 229 | 0.120 |
Why?
|
Protein Array Analysis | 1 | 2016 | 411 | 0.120 |
Why?
|
Sulfonamides | 2 | 2017 | 1932 | 0.120 |
Why?
|
Arthritis, Experimental | 1 | 2016 | 291 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 21596 | 0.120 |
Why?
|
Protein Structure, Tertiary | 3 | 2017 | 3847 | 0.120 |
Why?
|
Maleimides | 1 | 2014 | 112 | 0.120 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5724 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2014 | 28 | 0.120 |
Why?
|
Peptides, Cyclic | 1 | 2016 | 401 | 0.120 |
Why?
|
Morpholines | 1 | 2017 | 561 | 0.120 |
Why?
|
Benzothiazoles | 1 | 2015 | 247 | 0.120 |
Why?
|
Aldehydes | 1 | 2015 | 167 | 0.120 |
Why?
|
Drug Resistance, Viral | 2 | 2009 | 820 | 0.120 |
Why?
|
Haptens | 1 | 2013 | 166 | 0.120 |
Why?
|
Cricetulus | 1 | 2015 | 817 | 0.120 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2008 | 3760 | 0.120 |
Why?
|
Ketones | 1 | 2015 | 189 | 0.120 |
Why?
|
Antibodies | 3 | 2017 | 2459 | 0.120 |
Why?
|
Static Electricity | 1 | 2014 | 267 | 0.110 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2015 | 401 | 0.110 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 428 | 0.110 |
Why?
|
Thiazolidinediones | 1 | 2016 | 476 | 0.110 |
Why?
|
Electrons | 1 | 2014 | 268 | 0.110 |
Why?
|
CHO Cells | 1 | 2015 | 1407 | 0.110 |
Why?
|
Gene Library | 1 | 2015 | 1076 | 0.110 |
Why?
|
Interferons | 1 | 2016 | 704 | 0.110 |
Why?
|
Anemia, Sickle Cell | 1 | 2020 | 1017 | 0.110 |
Why?
|
Phenotype | 3 | 2021 | 16331 | 0.110 |
Why?
|
Half-Life | 2 | 2017 | 658 | 0.110 |
Why?
|
Disulfides | 1 | 2014 | 457 | 0.110 |
Why?
|
Azides | 1 | 2012 | 116 | 0.100 |
Why?
|
Protein Conformation | 3 | 2021 | 4013 | 0.100 |
Why?
|
Mutation | 5 | 2023 | 29717 | 0.100 |
Why?
|
Rats | 5 | 2017 | 24265 | 0.100 |
Why?
|
Molecular Biology | 1 | 2015 | 595 | 0.100 |
Why?
|
Pharmacokinetics | 1 | 2011 | 88 | 0.100 |
Why?
|
Immune System | 1 | 2017 | 804 | 0.100 |
Why?
|
Histone Deacetylases | 1 | 2016 | 729 | 0.100 |
Why?
|
Phenylpropanolamine | 1 | 2010 | 15 | 0.100 |
Why?
|
Cresols | 1 | 2010 | 28 | 0.100 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 834 | 0.100 |
Why?
|
Cyclobutanes | 1 | 2011 | 59 | 0.100 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2016 | 789 | 0.100 |
Why?
|
Cell Cycle | 1 | 2019 | 2964 | 0.090 |
Why?
|
Peptides | 1 | 2023 | 4392 | 0.090 |
Why?
|
Hydrogen Bonding | 1 | 2011 | 293 | 0.090 |
Why?
|
Caco-2 Cells | 1 | 2011 | 387 | 0.090 |
Why?
|
Oximes | 1 | 2012 | 309 | 0.090 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2021 | 1421 | 0.090 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 697 | 0.090 |
Why?
|
Interleukin-17 | 1 | 2016 | 900 | 0.090 |
Why?
|
Titrimetry | 1 | 2009 | 36 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2016 | 4414 | 0.090 |
Why?
|
Calorimetry | 1 | 2009 | 126 | 0.090 |
Why?
|
Apolipoproteins B | 1 | 2011 | 373 | 0.090 |
Why?
|
Histamine H2 Antagonists | 1 | 2011 | 165 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2276 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2015 | 1284 | 0.090 |
Why?
|
Ulcer | 1 | 2011 | 209 | 0.090 |
Why?
|
Luciferases | 1 | 2011 | 733 | 0.090 |
Why?
|
Benzene | 1 | 2009 | 100 | 0.090 |
Why?
|
Chelating Agents | 1 | 2011 | 380 | 0.090 |
Why?
|
Viral Nonstructural Proteins | 1 | 2011 | 241 | 0.090 |
Why?
|
Oligopeptides | 1 | 2015 | 1176 | 0.090 |
Why?
|
Oligonucleotides, Antisense | 1 | 2011 | 433 | 0.090 |
Why?
|
Piperidines | 1 | 2017 | 1602 | 0.080 |
Why?
|
Cross-Linking Reagents | 1 | 2012 | 694 | 0.080 |
Why?
|
Peer Review, Research | 1 | 2012 | 329 | 0.080 |
Why?
|
Drug Stability | 1 | 2009 | 290 | 0.080 |
Why?
|
Allosteric Site | 1 | 2008 | 103 | 0.080 |
Why?
|
Nicotine | 1 | 2013 | 677 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1899 | 0.080 |
Why?
|
Alkynes | 1 | 2009 | 306 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2023 | 5163 | 0.080 |
Why?
|
Solutions | 1 | 2008 | 426 | 0.080 |
Why?
|
Chromatography, Thin Layer | 1 | 2007 | 223 | 0.080 |
Why?
|
Molecular Mimicry | 2 | 2013 | 201 | 0.080 |
Why?
|
Antigens | 1 | 2013 | 1462 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2016 | 6608 | 0.080 |
Why?
|
Cyclopropanes | 1 | 2009 | 416 | 0.080 |
Why?
|
Benzoxazines | 1 | 2009 | 301 | 0.070 |
Why?
|
Nucleosides | 1 | 2007 | 138 | 0.070 |
Why?
|
Cell Survival | 1 | 2016 | 5872 | 0.070 |
Why?
|
NF-kappa B | 1 | 2015 | 2500 | 0.070 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 2211 | 0.070 |
Why?
|
RNA Interference | 1 | 2015 | 2890 | 0.070 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2006 | 143 | 0.070 |
Why?
|
Pyridines | 1 | 2017 | 2818 | 0.070 |
Why?
|
Aziridines | 1 | 2005 | 21 | 0.070 |
Why?
|
Trachea | 1 | 2011 | 1075 | 0.070 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 1144 | 0.060 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2006 | 187 | 0.060 |
Why?
|
Gene Silencing | 1 | 2011 | 1538 | 0.060 |
Why?
|
Mice | 8 | 2020 | 81045 | 0.060 |
Why?
|
Kinetics | 2 | 2014 | 6474 | 0.060 |
Why?
|
Vaccines | 1 | 2013 | 817 | 0.060 |
Why?
|
Benzhydryl Compounds | 1 | 2010 | 840 | 0.060 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18006 | 0.060 |
Why?
|
Neprilysin | 1 | 2006 | 439 | 0.060 |
Why?
|
Amines | 1 | 2005 | 278 | 0.060 |
Why?
|
Lipid A | 1 | 2002 | 67 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2006 | 790 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3504 | 0.050 |
Why?
|
Voltage-Dependent Anion Channel 1 | 1 | 2021 | 33 | 0.050 |
Why?
|
HIV | 1 | 2009 | 1600 | 0.050 |
Why?
|
Diazomethane | 1 | 2021 | 36 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2021 | 2552 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13814 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6483 | 0.050 |
Why?
|
Models, Biological | 1 | 2017 | 9581 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 18112 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2016 | 3701 | 0.040 |
Why?
|
Biomedical Research | 1 | 2014 | 3306 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7153 | 0.040 |
Why?
|
Hepatocytes | 2 | 2017 | 1209 | 0.040 |
Why?
|
Thiadiazoles | 1 | 2017 | 55 | 0.040 |
Why?
|
Sulfoxides | 1 | 2017 | 48 | 0.040 |
Why?
|
Oxidation-Reduction | 2 | 2016 | 2187 | 0.040 |
Why?
|
Escherichia coli | 2 | 2016 | 4214 | 0.040 |
Why?
|
Fluorescence Polarization | 1 | 2017 | 132 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 12071 | 0.040 |
Why?
|
Nucleotides, Cyclic | 1 | 2017 | 81 | 0.040 |
Why?
|
Janus Kinase 1 | 1 | 2016 | 104 | 0.040 |
Why?
|
Substrate Specificity | 2 | 2014 | 1802 | 0.040 |
Why?
|
Macrocyclic Compounds | 1 | 2016 | 72 | 0.040 |
Why?
|
Trinucleotide Repeats | 1 | 2017 | 261 | 0.040 |
Why?
|
Photochemical Processes | 1 | 2016 | 84 | 0.030 |
Why?
|
RNA Precursors | 1 | 2017 | 206 | 0.030 |
Why?
|
Haemophilus influenzae | 1 | 2016 | 171 | 0.030 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2017 | 242 | 0.030 |
Why?
|
Virus Replication | 2 | 2016 | 2531 | 0.030 |
Why?
|
Gram-Positive Bacteria | 1 | 2016 | 184 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2017 | 508 | 0.030 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2016 | 167 | 0.030 |
Why?
|
Rhinovirus | 1 | 2016 | 184 | 0.030 |
Why?
|
Gram-Negative Bacteria | 1 | 2016 | 270 | 0.030 |
Why?
|
GRB2 Adaptor Protein | 1 | 2014 | 103 | 0.030 |
Why?
|
Interferon-beta | 1 | 2016 | 323 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2017 | 731 | 0.030 |
Why?
|
Signal Transduction | 2 | 2015 | 23387 | 0.030 |
Why?
|
Activating Transcription Factor 2 | 1 | 2014 | 45 | 0.030 |
Why?
|
Diphtheria Toxoid | 1 | 2013 | 28 | 0.030 |
Why?
|
Aluminum Hydroxide | 1 | 2013 | 58 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2012 | 5304 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2013 | 6382 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2016 | 689 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1085 | 0.030 |
Why?
|
HIV-1 | 1 | 2011 | 6934 | 0.030 |
Why?
|
Antibody Affinity | 1 | 2013 | 253 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1655 | 0.030 |
Why?
|
RNA Splicing | 1 | 2017 | 907 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2017 | 2271 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2015 | 627 | 0.030 |
Why?
|
Somatostatin | 1 | 2014 | 459 | 0.030 |
Why?
|
Bronchi | 1 | 2016 | 840 | 0.030 |
Why?
|
Keratinocytes | 1 | 2016 | 797 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2015 | 600 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2013 | 708 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2017 | 1118 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2016 | 1099 | 0.030 |
Why?
|
Replicon | 1 | 2011 | 34 | 0.030 |
Why?
|
Th1 Cells | 1 | 2016 | 1056 | 0.020 |
Why?
|
Exons | 1 | 2017 | 2431 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2013 | 1094 | 0.020 |
Why?
|
Erythrocytes | 1 | 2020 | 2452 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2016 | 1200 | 0.020 |
Why?
|
HeLa Cells | 1 | 2017 | 3127 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2016 | 972 | 0.020 |
Why?
|
Species Specificity | 1 | 2015 | 2479 | 0.020 |
Why?
|
Vaccination | 1 | 2002 | 3256 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3862 | 0.020 |
Why?
|
Th17 Cells | 1 | 2016 | 765 | 0.020 |
Why?
|
Protein Engineering | 1 | 2013 | 541 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2017 | 14554 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 20774 | 0.020 |
Why?
|
Carbamates | 1 | 2011 | 195 | 0.020 |
Why?
|
Chemical Phenomena | 1 | 2009 | 517 | 0.020 |
Why?
|
Valine | 1 | 2011 | 413 | 0.020 |
Why?
|
Oxygen | 1 | 2020 | 4169 | 0.020 |
Why?
|
Pyrrolidines | 1 | 2011 | 342 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 1 | 2016 | 1210 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2013 | 1000 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5851 | 0.020 |
Why?
|
Gene Targeting | 1 | 2011 | 880 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 16665 | 0.020 |
Why?
|
Cell Membrane | 1 | 2017 | 3744 | 0.020 |
Why?
|
Solubility | 1 | 2009 | 1083 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2011 | 2335 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5975 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1525 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2016 | 3199 | 0.020 |
Why?
|
Immunoconjugates | 1 | 2013 | 897 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5867 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2011 | 2088 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1969 | 0.020 |
Why?
|
HIV Infections | 1 | 2011 | 16678 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2009 | 1059 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2016 | 3678 | 0.010 |
Why?
|
Solvents | 1 | 2005 | 302 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2021 | 11470 | 0.010 |
Why?
|
Hepacivirus | 1 | 2011 | 1372 | 0.010 |
Why?
|
Hydrazines | 1 | 2005 | 220 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12164 | 0.010 |
Why?
|
Water | 1 | 2009 | 1388 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
Pain | 1 | 2017 | 4961 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5655 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10472 | 0.010 |
Why?
|
Computational Biology | 1 | 2013 | 3518 | 0.010 |
Why?
|
Rabbits | 1 | 2006 | 4886 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9735 | 0.010 |
Why?
|
Asthma | 1 | 2016 | 5955 | 0.010 |
Why?
|
Smoking | 1 | 2013 | 8969 | 0.010 |
Why?
|
Swine | 1 | 2006 | 5934 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 13853 | 0.010 |
Why?
|
Kidney | 1 | 2011 | 7167 | 0.010 |
Why?
|
Liver | 1 | 2011 | 7470 | 0.010 |
Why?
|
Female | 4 | 2017 | 379592 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 8300 | 0.010 |
Why?
|
Male | 3 | 2017 | 349538 | 0.010 |
Why?
|